Cargando…

Urine NGAL as a biomarker for septic AKI: a critical appraisal of clinical utility—data from the observational FINNAKI study

BACKGROUND: Neutrophil gelatinase-associated lipocalin (NGAL) is released from kidney tubular cells under stress as well as from neutrophils during inflammation. It has been suggested as a biomarker for acute kidney injury (AKI) in critically ill patients with sepsis. To evaluate clinical usefulness...

Descripción completa

Detalles Bibliográficos
Autores principales:	Törnblom, Sanna, Nisula, Sara, Petäjä, Liisa, Vaara, Suvi T., Haapio, Mikko, Pesonen, Eero, Pettilä, Ville
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2020
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7188747/ https://www.ncbi.nlm.nih.gov/pubmed/32347418 http://dx.doi.org/10.1186/s13613-020-00667-7

Ejemplares similares

Early prolonged neutrophil activation in critically ill patients with sepsis
por: Törnblom, Sanna, et al.
Publicado: (2021)

Soluble CD73 in Critically Ill Septic Patients – Data from the Prospective FINNAKI Study
por: Vaara, Suvi T., et al.
Publicado: (2016)

Fluid balance‐adjusted creatinine in diagnosing acute kidney injury in the critically ill
por: Törnblom, Sanna, et al.
Publicado: (2021)

Predicting one-year mortality of critically ill patients with early acute kidney injury: data from the prospective multicenter FINNAKI study
por: Poukkanen, Meri, et al.
Publicado: (2015)

Urinary cell cycle arrest biomarkers and chitinase 3-like protein 1 (CHI3L1) to detect acute kidney injury in the critically ill: a post hoc laboratory analysis on the FINNAKI cohort
por: Hoste, Eric A., et al.
Publicado: (2020)

Fluid overload is associated with an increased risk for 90-day mortality in critically ill patients with renal replacement therapy: data from the prospective FINNAKI study
por: Vaara, Suvi T, et al.
Publicado: (2012)

Variation in the use of renal replacement therapy in patients with septic shock: a substudy of the prospective multicenter observational FINNAKI study
por: Poukkanen, Meri, et al.
Publicado: (2014)

Three-year mortality in 30-day survivors of critical care with acute kidney injury: data from the prospective observational FINNAKI study
por: Mildh, Henriikka, et al.
Publicado: (2016)

Association of endothelial and glycocalyx injury biomarkers with fluid administration, development of acute kidney injury, and 90-day mortality: data from the FINNAKI observational study
por: Inkinen, Nina, et al.
Publicado: (2019)

Hemodynamic variables and progression of acute kidney injury in critically ill patients with severe sepsis: data from the prospective observational FINNAKI study
por: Poukkanen, Meri, et al.
Publicado: (2013)

Does NGAL reduce costs? A cost analysis of urine NGAL (uNGAL) & serum creatinine (sCr) for acute kidney injury (AKI) diagnosis
por: Parikh, Amay, et al.
Publicado: (2017)

Genetic variants in SERPINA4 and SERPINA5, but not BCL2 and SIK3 are associated with acute kidney injury in critically ill patients with septic shock
por: Vilander, Laura M., et al.
Publicado: (2017)

Correction: Does NGAL reduce costs? A cost analysis of urine NGAL (uNGAL) & serum creatinine (sCr) for acute kidney injury (AKI) diagnosis
por: Parikh, Amay, et al.
Publicado: (2017)

Heme oxygenase-1 repeat polymorphism in septic acute kidney injury
por: Vilander, Laura M., et al.
Publicado: (2019)

Urine Neutrophil Gelatinase-associated Lipocalin (NGAL) for Prediction of Persistent AKI and Major Adverse Kidney Events
por: Lumlertgul, Nuttha, et al.
Publicado: (2020)

Burden of acute kidney injury and 90-day mortality in critically ill patients
por: Wiersema, Renske, et al.
Publicado: (2019)

The origin of plasma neutrophil gelatinase-associated lipocalin in cardiac surgery
por: Passov, Arie, et al.
Publicado: (2019)

Different applications of the KDIGO criteria for AKI lead to different incidences in critically ill patients: a post hoc analysis from the prospective observational SICS-II study
por: Wiersema, Renske, et al.
Publicado: (2020)

Sepsis and AKI in Clinical Emergency Room Patients: The Role of Urinary NGAL
por: Si Nga, Hong, et al.
Publicado: (2015)

Population-based incidence, mortality and quality of life in critically ill patients treated with renal replacement therapy: a nationwide retrospective cohort study in finnish intensive care units
por: Vaara, Suvi T, et al.
Publicado: (2012)

Protocol and statistical analysis plan for the REstricted fluid therapy VERsus Standard trEatment in Acute Kidney Injury—REVERSE‐AKI randomized controlled pilot trial
por: Vaara, Suvi T., et al.
Publicado: (2020)

Six-month survival and quality of life of intensive care patients with acute kidney injury
por: Nisula, Sara, et al.
Publicado: (2013)

Common Inflammation-Related Candidate Gene Variants and Acute Kidney Injury in 2647 Critically Ill Finnish Patients
por: Vilander, Laura M., et al.
Publicado: (2019)

Serum and Urinary NGAL in Septic Newborns
por: Smertka, Mike, et al.
Publicado: (2014)

IL-10 Combined with NGAL Has Diagnostic Value for AECOPD Combined with AKI
por: Wei, Bing, et al.
Publicado: (2020)

Two subphenotypes of septic acute kidney injury are associated with different 90-day mortality and renal recovery
por: Wiersema, Renske, et al.
Publicado: (2020)

Restrictive fluid management versus usual care in acute kidney injury (REVERSE-AKI): a pilot randomized controlled feasibility trial
por: Vaara, Suvi T., et al.
Publicado: (2021)

NGAL: an emerging tool for predicting severity of AKI is easily detected by a clinical assay
por: Gabbard, Wes, et al.
Publicado: (2010)

POS-870 NGAL and microalbuminuria as AKi biomarkers in COVID-19 hospitalized patients with pneumonia
por: Rizo Topete MD, L., et al.
Publicado: (2022)

Heparin-binding protein (HBP) improves prediction of sepsis-related acute kidney injury
por: Tverring, Jonas, et al.
Publicado: (2017)

Evaluation of plasma and urine neutrophil gelatinase-associated lipocalin (NGAL) as an early diagnostic marker of acute kidney injury (AKI) in critically ill trauma patients
por: Gupta, Babita, et al.
Publicado: (2023)

Urinary Biomarkers Indicative of Apoptosis and Acute Kidney Injury in the Critically Ill
por: Vaara, Suvi T., et al.
Publicado: (2016)

Clinical Implementation of NGAL Testing to Improve Diagnostic Assessment of AKI Episodes in a Canadian Center
por: Côté, Jean-Maxime, et al.
Publicado: (2022)

The Effects of Febuxostat on Urine NGAL and Urine KIM-1 in Patients with Hyperuricemia
por: Tang, Yushang, et al.
Publicado: (2022)

Urine NGAL and KIM-1 in children and adolescents with hyperuricemia
por: Tomczak, Justyna, et al.
Publicado: (2013)

Response to different furosemide doses predicts AKI progression in ICU patients with elevated plasma NGAL levels
por: Matsuura, Ryo, et al.
Publicado: (2018)

INtravenous Contrast computed tomography versus native computed tomography in patients with acute Abdomen and impaired Renal functiOn (INCARO): a multicentre, open-label, randomised controlled trial - study protocol
por: Räty, Panu, et al.
Publicado: (2020)

Retracted: The Effects of Febuxostat on Urine NGAL and Urine KIM-1 in Patients with Hyperuricemia
por: Healthcare Engineering, Journal of
Publicado: (2023)

NGAL/hepcidin-25 ratio and AKI subtypes in patients following cardiac surgery: a prospective observational study
por: Elitok, Saban, et al.
Publicado: (2021)

The utility of neutrophil gelatinase-associated Lipocalin (NGAL) as a marker of acute kidney injury (AKI) in critically ill patients
por: Khawaja, Shabnum, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_oh30oaf9g0ssd6h8l8mo3aq3sd